Pharmaceuticals

Global Psychedelic Drugs Market Forecast to Reach $5.94 Billion by 2029, Driven by 9.7% CAGR

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#How Large Is the Psychedelic Drugs Market Expected to Be in 2029?#_x000D_

The market size for anti-obesity has experienced significant growth in the past years. It is projected to surge from $3.74 billion in 2024 to $4.1 billion in 2025, marking a compound annual growth rate (CAGR) of 9.7%. The expansion witnessed in the historic period is linked to the rise in obesity rates, heightened awareness and education, alterations in lifestyle, and government involvements._x000D_

_x000D_

In the coming years, robust expansion is projected in the antiobesity market size. The market is estimated to climb to “$5.94 billion in 2029 with a compound annual growth rate (CAGR) of 9.7%. The boost during this forecast period can be ascribed to the expansion of the market and globalization. The period will likely see major trends such as research and development, a focus on patient-centric approaches, increased insurance coverage, technological strides, a rise in digital health and telemedicine, the emergence of new drug therapies, advancements in bariatric surgery, solutions available over-the-counter (otc), behavioral strategies, and applications for nutrition and weight management._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp_x000D_

_x000D_

#What Are The Contributors To Demand In The Psychedelic Drugs Market?#_x000D_

The escalation in mental illness incidences is projected to fuel the expansion of the psychedelic drugs market in the future. Mental illnesses are health issues characterized by alterations in feelings, cognition, or behavior. These illnesses encompass discomfort and post-traumatic stress disorder. Psychedelic drugs, which are employed to manage depression and post-traumatic stress disorder, can reduce mental illnesses with consistent use. For example, the National Centre for Social Research, a social research institution based in the UK, reported in November 2022 that the percentage of 17- to 19-year-olds suspected of having a mental disorder rose from 17.4% in 2021 to 25.7% in 2022. Thus, the swelling number of mental illness cases is stimulating the growth of the psychedelic drugs market._x000D_

_x000D_

The antiobesity market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Class: Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs _x000D_

2) By Type: Prescription Drugs (Rx), OTC Drugs _x000D_

3) By Medication: Monotherapies, Polytherapies _x000D_

_x000D_

Subsegments:_x000D_

1) By Peripherally Acting Anti-Obesity Drugs: Orlistat, Lorcaserin _x000D_

2) By Centrally Acting Anti-Obesity Drugs: Phentermine, Topiramate, Naltrexone-Bupropion Combination, Liraglutide_x000D_

_x000D_

#What Trends Are Currently Influencing Growth In The Psychedelic Drugs Market?#_x000D_

Leading firms in the anti-obesity drugs market are concentrating on new product innovation, such as Mounjaro (tirzepatide), to deliver dependable services to consumers. This drug is employed in the treatment of obesity or overweight individuals with weight-related health conditions. For example, in October 2022, Eli Lilly and Company, a US pharmaceutical firm, released Mounjaro (tirzepatide). The drug has received fast track designation approval from the US Food and Drug Administration (FDA), a federal agency. Mounjaro (tirzepatide) is an injectable anti-obesity medication aiding individuals dealing with obesity in reaching their weight loss objectives. It is prescribed for adults with type 2 diabetes, in combination with diet and exercise, for improved blood sugar levels._x000D_

_x000D_

#Who Are The Top-Ranked Companies In The Psychedelic Drugs Market Today?#_x000D_

Major companies operating in the antiobesity market include F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Novartis International AG, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Allergan Aesthetics, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Intas Pharmaceuticals Ltd., Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd._x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report_x000D_

_x000D_

#How Is Psychedelic Drugs Market Adoption Varying Across Different Regions And Sectors?#_x000D_

North America was the largest region in the anti-obesity market in 2024. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3403&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_